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are one of the main reasons for emergency department visits and hospital admissions of injection drug users. 2, 3 Furthermore, antimicrobial-resistant S. aureus, such as methicillin-resistant S. aureus (MRSA), may cause outbreaks among injection drug users. 4 Such an outbreak recently occurred in Switzerland. 5 Colonization with S. aureus, particularly nasal carriage of S. aureus, plays a key role in the pathogenesis and increases the risk of S. aureus infection. 6, 7 However, the biological mechanisms of nasal colonization by S. aureus are still unclear. 8 Tuazon and Sheagren showed that active injection drug users have a higher rate of S. aureus colonization of the skin and nose than does the general population. 9 This finding and the observation of higher rates of S. aureus carriage among patients with insulin-dependent diabetes mellitus, patients receiving hemodialysis or continuous ambulator y peritoneal dialysis, and patients undergoing desensitization therapy with allergen injections led to the hypothesis that repeated puncture of the skin by needles or catheters increases the rate of S. aureus carriage, even under strict aseptic conditions. 6, 10 The first aim of the current study was to analyze the association between intravenous drug use and S. aureus carriage by comparing the rate of S. aureus colonization among injection drug users treated in an injection opiate maintenance program with at least twice daily injections of heroin with that among injection drug users treated in a conventional oral methadone program. Second, we assessed the prevalence of MRSA colonization among injection drug users treated in these two opiate maintenance programs in Basel, Switzerland.
METHODS

Study Population
All 
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2001, were asked to participate in the study. The first program is a traditional oral methadone program. Patients receive their oral methadone doses every day or at least weekly. The second program is an intravenous heroin substitution program and enrolls severely addicted patients for whom other treatments have failed. 3, 11 Participants receive and have to inject the prescribed dose of heroin at the clinic under direct supervision, usually twice daily. They have to use the sterile injection equipment provided. In addition to heroin, patients are given oral methadone if needed.
Risk Factors for S. aureus Carriage
Information on drug use in and outside the program, medications, medical conditions, and risk factors for S. aureus carriage was collected from all participants by questionnaire, and checked by chart review. All of the participants underwent an interview and a skin examination performed by one of the investigators.
Microbiological Studies
Specimens were obtained from the anterior nares, the pharynx, and, if present, skin wounds with a sterile polyester fiber-tipped swab moistened with sterile saline. Swabs were transported to the laboratory in a transport tube (Transwab MW170, Medical Wire & Equipment, Corsham, United Kingdom) and cultured within 24 hours in Chapman broth (7.5% NaCl) at 35°C overnight. A loop was then subcultured on Columbia sheep blood agar with colistin and nalidixic acid. After incubation at 35°C for 24 hours, colonies with morphology consistent with S. aureus were identified by Gram stain, catalase test, latex agglutination test for the detection of clumping factor, protein A, and capsular polysaccharides of S. aureus (Pastorex Staph-Plus, Bio-Rad, Marnes-la-Coquette, 
Statistical Analysis
Categorical variables were compared using a twosided chi-square test or Fisher's exact test and continuous variables using a t test. Independent predictors of S. aureus carriage were determined by multiple stepwise logistic regression analysis. All variables with a P value of .10 or less were entered into the model. Statistical analyses were performed using SPSS software (version 10.1.3; SPSS, Inc., Chicago, IL).
The study was approved by the Research Ethics Committee of the Cantons Basel Stadt and Basel Land. Written informed consent was obtained from each study participant.
RESULTS
Study Population
Seventy (56%) of 125 patients from the oral methadone program and 94 (74%) of 127 patients from the intravenous heroin program agreed to participate in the study. The demographic data of study participants and characteristics that could affect the rate of S. aureus carriage are presented in Table 1 . None of the study participants suffered from insulin-dependent diabetes mellitus. Only 1 patient, an S. aureus carrier, used nasal steroids, and 2 female patients used estrogens (1 was colonized with S. aureus).
S. aureus Carriage
The addicts treated in the intravenous heroin substitution program had a significantly lower overall rate of S. aureus carriage (ie, colonization of at least the nose, pharynx, or skin [37 of 94 (39.4%) vs 42 of 70 (60%); P = .009]) and a significantly lower rate of nasal carriage (21 of 94 [22. 3%] vs 30 of 70 [42.9%]; P = .005) than did the addicts treated in the oral methadone program. The prevalence of S. aureus carriers with colonization in the pharynx only was similar in the two groups (Table 1) . Thirteen (54.2%) of 24 patients from the oral methadone program who did not inject drugs in the month preceding the study were S. aureus carriers.
Risk Factors for S. aureus Carriage
Characteristics associated with S. aureus carriage are presented in Table 2 . The following variables were included in the logistic regression analysis model: treatment in the oral methadone program, use of intravenous heroin, heroin smoking, cocaine smoking, use of intravenous methadone, histor y of hepatitis C, and hospitalization in the month preceding the study. In this model, being treated in the oral methadone program was the only independent predictor of S. aureus carriage (odds ratio, 2.27; 95% confidence inter val, 1.19 to 4.31; P = .012).
Susceptibility to Oxacillin
All S. aureus isolates were susceptible to oxacillin.
DISCUSSION
The overall rate of S. aureus carriage found in the current study among addicts treated in an intravenous heroin maintenance program (39.4%) is almost identical to the rate previously reported by Tuazon and Sheagren for active injection drug users (35%). 9 The rate of nasal carriage of S. aureus (22.3%) is similar to the rate recently found among healthy university students (26.2%), 13 and is lower than the mean rate of carriage of 37.2% in the general population calculated by Kluytmans et al. from 18 published studies involving 13,873 individuals. 6 The current study also showed that addicts injecting heroin in the setting of a substitution program had a significantly lower overall rate of S. aureus carriage and a lower rate of nasal carriage than did addicts treated in an oral methadone program. They had an even lower rate of S. aureus carriage than those addicts in the oral methadone program who did not inject street drugs or methadone in the month preceding the study (39.4% vs 54.2%).
These findings suggest that the regular use of sterile needles under aseptic conditions per se does not increase the rate of S. aureus carriage. This conclusion is consistent with the results of two previous studies. In the first study involving 217 active and former drug users, Holbrook et al. found no association between injection drug use and nasal colonization by S. aureus, although nasal carriage of S. aureus was independently correlated with inhalational drug use in individuals infected with human immunodeficiency virus. 14 The second study demonstrated that the higher rate of nasal carriage of S. aureus found among patients receiving allergen-injection immunotherapy is probably related to the atopic constitution of these patients, manifested by a high prevalence of atopic dermatitis and eczema, rather than to the regular use of needles for the desensitization therapy. 13 It is unclear why treatment in the oral methadone program was associated with a higher rate of S. aureus carriage. The anterior nares are the ecologic niches of S. aureus and provide a reservoir from which the skin is colonized. 6, 8 It is not known exactly how S. aureus binds to the nasal mucosa. Previous studies described S. aureus adhesion to mucin, 15 and to nasal epithelial cells. 16 It is also thought that damaged mucosa is more likely to become colonized with S. aureus because underlying surfaces contain tissue constituents, such as microbial surface components recognizing adhesive matrix molecules, that promote colonization. 17 Sixty-six percent of the patients in the oral methadone program continued to use intravenous drugs despite methadone substitution. Addicts treated with oral methadone may inject or smoke contaminated street drugs more frequently and these may cause nasal mucosal damage. This illegal drug use may also take place in settings with poor hygiene and shared use of drug paraphernalia, thus facilitating transmission February 2004 of S. aureus. 17 In fact, in the current study, the patients treated in the oral methadone program snorted heroin, smoked heroin or cocaine, and used intravenous methadone and intravenous street drugs more frequently than did the patients in the intravenous heroin program. These factors and additional factors other than the regular use of needles under aseptic conditions may interact and increase the rate of S. aureus colonization among injection drug users. A larger study population would be necessary to identify such factors.
Complications associated with injection drug use are frequently the consequence of the illegal status of street drugs. Therefore, in several countries, harm reduction measures have been developed, including implementation of supervised injecting facilities where injection drug users are provided with sterile injecting equipment, opiate substitution programs, and programs offering intravenous heroin substitution to addicted patients for whom other treatments have failed. 11 It has been shown that injection opiate maintenance programs improve health status and social functioning, reduce the selfreported use of illicit drugs and criminal activity, 11, 18 reduce the incidence of hepatitis B and C, 19 and may decrease the incidence of human immunodeficiency virus and hepatitis A virus infection. 20 The current study found a low rate of S. aureus carriage among injection drug users in an intravenous heroin maintenance program. This low rate of S. aureus carriage may result in a low incidence of S. aureus infections in this population. This hypothesis is supported by a previous study showing a significant decrease in the prevalence of skin abscesses and cellulitis, which are predominantly caused by S. aureus, 1 among injection drug users in an intravenous heroin program. 21 All S. aureus isolates of the current study in Basel were susceptible to oxacillin. This result is surprising considering the recent MRSA epidemic among injection drug users in the neighboring city of Zurich. 5 However, this finding mirrors the low MRSA prevalence (4%) among nosocomial S. aureus isolates in Basel, 22 and suggests that the injection drug user populations in the two cities are not in close contact. This observation also illustrates the importance of regular surveillance of the local epidemiologic situation regarding antibiotic-resistant organisms.
Addicts treated in an intravenous heroin maintenance program had a lower rate of S. aureus carriage than did addicts treated in an oral methadone program. Factors other than the regular use of needles under aseptic conditions may predispose injection drug users to S. aureus carriage. Further studies are necessary to investigate whether the lower rate of S. aureus carriage leads to a lower incidence of S. aureus infections among injection drug users treated with intravenous heroin.
